Levofloxacina Combino

Levofloxacin, the active ingredient in Levofloxacina Combino, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It provides broad‑spectrum antibacterial activity against Gram‑negative and Gram‑positive pathogens and is prescribed for serious infections in adult and pediatric patients when oral therapy is unsuitable.

GNH USA supplies Levofloxacina Combino as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company emphasizes strict quality assurance and adherence to global regulatory standards throughout the supply chain.

Levofloxacin is a fluoroquinolone antibiotic used to treat a range of serious bacterial infections.

- Complicated urinary tract infection: eradicates susceptible Gram‑negative and Gram‑positive organisms, achieving clinical cure. - Intra‑abdominal infection: provides coverage against common intra‑abdominal pathogens, facilitating resolution of infection. - Community‑acquired bacterial pneumonia: eliminates causative bacteria, improving respiratory function and recovery. - Skin and soft‑tissue infection: targets Gram‑positive and Gram‑negative skin pathogens, leading to healing. - Bacterial prostatitis: penetrates prostatic tissue to eradicate infecting organisms and relieve symptoms.

Levofloxacina Combino may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: skin erythema or itching. - Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis after antibiotic exposure. - Peripheral neuropathy: numbness or tingling in extremities. - Seizures: especially in patients with CNS disorders.

When using Levofloxacina Combino, consider the following precautions.

- Renal impairment: monitor kidney function and adjust dose if necessary. - History of tendon disorders: avoid use in patients with prior tendon injury or inflammation. - QT prolongation risk: obtain baseline ECG and monitor cardiac rhythm. - Concomitant corticosteroids: increased risk of tendon rupture; use with caution. - Pregnancy and lactation: only prescribe if benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacina Combino can interact with several medicines.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase CNS stimulation. - Other QT‑prolonging agents (e.g., macrolides, antiarrhythmics): additive risk of cardiac arrhythmias. - Systemic corticosteroids: heightened risk of tendon rupture.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption; separate dosing by at least 2 hours. - Warfarin: may enhance anticoagulant effect; monitor INR closely. - Theophylline: increased plasma concentrations; watch for toxicity signs.